○ 주요 학력, 경력 (Experience)
2012-present Sungkyunkwan University School of Medicine (Professor)
2010-present Samsung Advanced Institute for Health Sciences and Technology (Professor)
2006-2012 Sungkyunkwan University School of Medicine (Associate Professor)
2002-2006 National Cancer Center (Senior Research Associate)
1998-2000 Harvard Medical School (Post-doctoral fellow)
1994-1998 University of Glasgow (UK) / National Institute for Medical Research (Ph.D.)

○ 연구분야(Research Field)
  ▪New Regulatory mechanism and Pathogenesis mechanism of tumor immunity, immune checkpoint and autoimmunity
  ▪ Development of therapeutic technology for blood cancer, lymphoma and autoimmune diseases using low molecular compounds and antibodies
  ▪ A new mechanism of disease development and treatment of molecular disease by Ssu72 (dual protein phosphatase) and a new type of Pellino1 (ubiquitin E3 ligase)

○ 주요 연구논문(Major Research Achievements)
  ▪ Pellino1 is a double-strand break responsive E3 ligase which is required for reversible ATM activation via NBS1 ubiquitination. Nature Communications 2018 in revision (IF 12.353) 
  ▪ Peli1 Selectively Targets Kinase-Active RIP3 for Ubiquitylation-Dependent Proteasomal Degradation. Molecular Cell 2018, 7(70):920-935 (IF 14.248)  
  ▪ The chromatin remodeler RSF1 controls centromeric histone modifications to coordinate chromosome segregation. Nature Communications 2018, In press (IF 12.353)
  ▪ Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72 protein phosphatase. Hepatology 2015, 63(2016): 247-259 (IF 14.079)

○ 연구협력 필요 분야(Research Interest)
  ▪ Organic synthesis and Drug design
  ▪ Screening using bioinformatics database
  ▪ Mass analysis and target detection using high-resolution equipment

○ 연구협력 가능 분야(Research Collaboration)
  ▪ Cell signaling mechanism analysis
  ▪ Genetically Modified Mouse Model Pinotyping
  ▪ Verification of candidate for treatment substance safety